Differential regulation of IL-22BP in Crohn’s disease versus ulcerative colitis

Differential regulation of IL-22BP in Crohn’s disease versus ulcerative colitis

Bibliographic Details
Main Authors:	Martin, Jérôme, Bossard, Céline, Boureille, Arnaud, Josien, Régis
Format:	Online
Language:	English
Published:	BioMed Central 2011
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242237/

Similar Items

A subset of dendritic cells as a major and constitutive source of IL-22BP
by: Martin, Jérôme, et al.
Published: (2011)

Differential expression of prolyl hydroxylase 1 in patients with ulcerative colitis versus patients with Crohn’s disease/infectious colitis and healthy controls
by: Van Welden, Sophie, et al.
Published: (2013)

MicroRNA signatures differentiate Crohn’s disease from ulcerative colitis
by: Schaefer, Jeremy S, et al.
Published: (2015)

Expressing the Differences between Crohn Disease and Ulcerative Colitis
by: Wijmenga, Cisca
Published: (2005)

Mucosal Barrier in Ulcerative Colitis and Crohn's Disease
by: Dorofeyev, A. E., et al.
Published: (2013)

Carbohydrate Intake in the Etiology of Crohn's Disease and Ulcerative Colitis
by: Chan, Simon S. M., et al.
Published: (2014)

Association of the interleukin-22 genetic polymorphisms with ulcerative colitis
by: Chi, Hong Gang, et al.
Published: (2014)

Update on the role of modified release mesalamine in the management of ulcerative colitis and Crohn’s disease
by: Doherty, Glen A, et al.
Published: (2009)

Mucosa-associated but not luminal Escherichia coli is augmented in Crohn’s disease and ulcerative colitis
by: de Souza, Helton Luis, et al.
Published: (2012)

Is there a role for vedolizumab in the treatment of ulcerative colitis and Crohn’s disease?
by: Gilroy, Leah, et al.
Published: (2014)

Differences in Immunophenotyping of Mucosal Lymphocytes Between Ulcerative Colitis and Crohn’s Disease
by: Lee, Heung Bum, et al.
Published: (1997)

Population pharmacokinetics‐pharmacodynamics of vedolizumab in patients with ulcerative colitis and Crohn's disease
by: Rosario, M., et al.
Published: (2015)

Infections Requiring Hospitalization as Predictors of Pediatric-Onset Crohn's Disease and Ulcerative Colitis
by: Hutfless, Susan, et al.
Published: (2015)

Selective biologics for ulcerative colitis and Crohn’s disease – clinical utility of vedolizumab
by: Petkau, Jill MV, et al.
Published: (2016)

IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine
by: Huber, Samuel, et al.
Published: (2012)

Quality of Life Is Related to Fecal Calprotectin Concentrations in Colonic Crohn Disease and Ulcerative Colitis, but not in Ileal Crohn Disease
by: Gauss, Annika, et al.
Published: (2016)

Quality of Life Is Related to Fecal Calprotectin Concentrations in Colonic Crohn Disease and Ulcerative Colitis, but not in Ileal Crohn Disease: Erratum
Published: (2016)

Peripheral blood leukocytes express differential chemokine receptor profiles in irritable bowel syndrome, Crohn’s disease and ulcerative colitis
by: Linton, Ludvig, et al.
Published: (2012)

Immunohistochemical Analysis of Retinoblastoma and β-Catenin as an Assistant Tool in the Differential Diagnosis between Crohn's Disease and Ulcerative Colitis
by: Soletti, Rossana Colla, et al.
Published: (2013)

Interleukin-22 binding protein (IL-22BP) is constitutively expressed by a subset of conventional dendritic cells and is strongly induced by retinoic acid
by: Martin, JCJ, et al.
Published: (2013)

National Association for Crohn's and Colitis (NACC)
Published: (2002)

National Association for Colitis and Crohns disease
Published: (2004)

Clinical monitoring: infliximab biosimilar CT-P13 in the treatment of Crohn’s disease and ulcerative colitis
by: Keil, Radan, et al.
Published: (2016)

IL23 as a novel serum based biomarker in ulcerative colitis- an editorial
by: Chakraborty, Subhankar
Published: (2012)

THE ROLE OF IL-13 AND NK T CELLS IN EXPERIMENTAL AND HUMAN ULCERATIVE COLITIS
by: Fuss, Ivan J., et al.
Published: (2008)

Medical Therapy of Active Ulcerative Colitis
by: Bürger, Martin, et al.
Published: (2015)

Peripheral Blood Based Discrimination of Ulcerative Colitis and Crohn’s Disease from Non-IBD Colitis by Genome-Wide Gene Expression Profiling
by: Sipos, Ferenc, et al.
Published: (2011)

Infliximab in ulcerative colitis
by: Levin, Avi, et al.
Published: (2008)

Ulcerative Colitis in Infancy
by: Rukunuzzaman, Md, et al.
Published: (2011)

AUTOANTIBODIES IN HUMAN ULCERATIVE COLITIS
by: Broberger, Ove, et al.
Published: (1959)

Turner Syndrome with Ulcerative Colitis
by: Hyodo, Hiromi, et al.
Published: (2009)

Unusual polyposis in ulcerative colitis
by: Amarapurkar, Anjali Deepak, et al.
Published: (2014)

Golimumab for the treatment of ulcerative colitis
by: Löwenberg, Mark, et al.
Published: (2014)

Golimumab in unresponsive ulcerative colitis
by: Lippert, Elisabeth, et al.
Published: (2014)

Ulcerative colitis in Malaysians
by: Chen Chee Hoong
Published: (1996)

Management of ulcerative colitis
by: Fell, John M, et al.
Published: (2016)

Chronic Ulcerative Colitis
by: Sen, S. C.
Published: (1939)

Chronic Ulcerative Colitis
by: Chopra, R. N., et al.
Published: (1939)

Tacrolimus for the Treatment of Ulcerative Colitis
by: Matsuoka, Katsuyoshi, et al.
Published: (2015)

Biological therapy for ulcerative colitis
by: Arora, Zubin, et al.
Published: (2015)